Pancreatic cancer: New approach may prolong survival

Latest Posts

Another Player in Advanced Bladder Cancer

By Lizzy

The FDA expanded indications for sacituzumab govitecan-hziy (Trodelvy) with an accelerated approval for previously treated advanced bladder cancer. The conditional approval pertains to patients with...

Comments closed

Reassuring Data on Tranexamic Acid and Blood Clots

By Lizzy

Safety of tranexamic acid (TXA), even at higher doses, was upheld in a meta-analysis. Across 216 randomized trials in various medical disciplines, the incidence of...

Comments closed

CaMKII Inhibitor Disappoints in Post-MI Cardioprotection

By Lizzy

The first calcium/calmodulin-dependent protein kinase II (CaMKII) inhibitor to be tested for prevention of post-MI heart failure stumbled in a small phase II trial. Among...

Comments closed

House Passes Bill to Forestall $18 Billion in Medicare Cuts

By Lizzy

WASHINGTON -- The House voted 384-38 Tuesday evening to rescind one of two scheduled Medicare cuts, sending the bill on to President Biden for his...

Comments closed

CDC Issues Health Advisory on J&J Shot; Pfizer Ramps Up; STDs at All-Time High

By Lizzy

Note that some links may require registration or subscription. CDC issued a Health Advisory Alert about the single-dose Johnson & Johnson COVID-19 vaccine that was...

Comments closed

Pancreatic cancer is often treatment-resistant, but new light shed in a mouse study has ‘more than doubled survival’ and may lead to new therapies.

Source: MedicalNewsToday.com